Ozempic vs Wegovy 2026: Cost, Results & How to Save
Same molecule. Same manufacturer. Two different prices, two different labels, and two very different conversations with your insurance company.
If you've been quoted $998 for one and $1,350 for the other, the Ozempic vs Wegovy question isn't really about chemistry — it's about which one your prescriber can justify writing, and which one you can actually afford to keep filling in month three.
At a glance
- Both are semaglutide from Novo Nordisk. Wegovy is approved for weight management; Ozempic is approved for type 2 diabetes.
- Wegovy goes to a higher maximum dose (2.4 mg weekly, or 7.2 mg for Wegovy HD) than Ozempic (2 mg weekly).
- List prices are roughly $1,350/month for Wegovy and $998/month for Ozempic — almost nobody paying cash pays that.
- Self-pay prices in 2026 land between $149 and $499 a month depending on format and dose, and the pill versions are the cheapest entry point.
- Per milligram of semaglutide, Wegovy is usually the better value at maintenance dose — which is the opposite of what the sticker prices suggest.
Is Wegovy the same as Ozempic?
Chemically, yes. Both contain semaglutide, a GLP-1 receptor agonist that slows gastric emptying, blunts appetite signaling in the brain, and prompts insulin release when blood sugar rises.
What differs is the FDA label, and the label is what drives the dose, the pen design, the price, and whether your plan pays.
Ozempic is approved to treat type 2 diabetes in adults, to lower cardiovascular risk in adults with type 2 diabetes and heart disease, and to slow kidney disease progression in adults with type 2 diabetes and chronic kidney disease.
Wegovy is approved for chronic weight management in adults and children 12 and older, for cardiovascular risk reduction in adults with obesity or overweight plus heart disease, and for treating metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate-to-advanced liver fibrosis.
That's why they aren't interchangeable at the pharmacy counter even though a chemist couldn't tell the vials apart.
| Ozempic | Wegovy | |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Primary approval | Type 2 diabetes | Chronic weight management |
| Max weekly injection | 2 mg | 2.4 mg (7.2 mg as Wegovy HD) |
| Pen type | Multi-dose, you dial the dose | Single-use prefilled |
| Pill version | Yes, up to 9 mg daily | Yes, up to 25 mg daily |
| List price (approx.) | $998/month | $1,350/month |
Ozempic vs Wegovy cost in 2026: the real numbers
Here's where most comparison articles stop short. They'll tell you coverage "varies" and send you to your plan. Useful if you have a plan. Useless if you're paying cash.
These are the self-pay prices in play as of October 2026:
| Format and dose | Ozempic self-pay | Wegovy self-pay |
|---|---|---|
| Injection, 0.25–1 mg | ~$349/month | ~$349/month ($199 for first 2 fills, new patients) |
| Injection, 2 mg | ~$499/month | ~$349/month |
| Injection, 7.2 mg (Wegovy HD) | Not available | ~$399/month |
| Pill, 1.5 mg | ~$149/month | ~$149/month |
| Pill, 4 mg | ~$199/month | ~$199/month |
| Pill, 9–25 mg | ~$299/month | ~$299/month |
Those are Novo Nordisk's direct self-pay pharmacy prices — a cash transaction, not a benefit you have to qualify for. Cash-pay networks price the same products independently: CanAmerica Plus lists the Wegovy pen from around $325 on its pricing calculator, with the final figure depending on strength and quantity.
Novo Nordisk has also announced list price cuts of up to 50% taking effect January 1, 2027, which should pull the insured-and-still-paying-coinsurance crowd down closer to where cash payers already are.
The cost-per-milligram math nobody shows you
Compare the sticker prices and Ozempic looks like the cheaper drug. Compare what you get for the money and the picture flips.
At $349 a month, a 1 mg weekly Ozempic dose delivers about 4 mg of semaglutide. At the same $349, Wegovy at its 2.4 mg maintenance dose delivers roughly 9.6 mg. On the 2 mg Ozempic dose you'd pay $499 for about 8 mg — more money for less drug than Wegovy at maintenance.
So if the goal is weight management and you're paying cash, the "expensive" drug is frequently the better deal. If the goal is glucose control at 0.5 mg or 1 mg weekly, Ozempic at $349 is priced the same as Wegovy and comes in a multi-dose pen, which some people simply prefer handling.
Savings tip: Price the pill before you assume the injection is your only option. At $149/month for the starting dose, oral semaglutide is the cheapest brand-name route into either drug — and the dose schedule starts identically for both. Absorption is less reliable than injection, so it's a conversation to have with your prescriber rather than a swap to request blind.
Ozempic vs Wegovy for weight loss: what the trials actually show
Wegovy wins on weight loss, and the reason is dose, not molecule.
In the STEP 1 trial, adults without diabetes taking semaglutide 2.4 mg weekly lost about 14.9% of their starting body weight over 68 weeks. Wegovy HD at 7.2 mg has produced average losses closer to 19%. The oral 25 mg Wegovy dose lands in similar territory to the 2.4 mg injection.
Ozempic's weight data comes from diabetes trials, where average loss at 1 mg weekly runs in the 4–6% range. Two things drive the gap: the lower ceiling dose, and the fact that people with type 2 diabetes tend to lose less weight on GLP-1s than people without it.
| Regimen | Average weight loss | Trial context |
|---|---|---|
| Ozempic 1 mg weekly | ~4–6% | Type 2 diabetes (SUSTAIN program) |
| Wegovy 2.4 mg weekly | ~14.9% at 68 weeks | Obesity/overweight (STEP 1) |
| Wegovy HD 7.2 mg weekly | ~19% | Obesity/overweight |
Worth being honest about: these are averages from trials with structured diet and activity support built in. Individual results spread widely in both directions, and weight tends to return when the medication stops.
Side effects: does the higher dose cost you more nausea?
Somewhat, yes. Both drugs carry the same gastrointestinal profile — nausea, vomiting, diarrhea, constipation, abdominal pain — and higher doses make those more likely. Wegovy, by design, spends most of your treatment at a higher dose than Ozempic.
Both share semaglutide's boxed warning for thyroid C-cell tumors, which matters if you or a close relative has had medullary thyroid carcinoma or MEN 2. Both should be avoided in pregnancy and in severe gastroparesis. Pancreatitis, gallbladder problems, and diabetic retinopathy changes are less common but documented.
The practical defense is the same for both: hold each dose step for the full four weeks, and don't let anyone rush your titration to chase faster results. Side effects are the most common reason people quit — and quitting is the most expensive outcome of all, because you've paid for months of drug and kept none of the benefit.
Pens, pills, and the format question
Ozempic's multi-dose pen holds several weeks of drug and requires you to dial your dose. Wegovy's pen is single-use and prefilled — fewer steps, no dialing, more plastic.
Both now come as a daily tablet taken first thing in the morning with no more than 4 oz of plain water, then at least 30 minutes before anything else goes in your stomach. That window is genuinely restrictive for a lot of people, and skipping it undercuts absorption.
A note on the Ozempic pen: because it's multi-dose, patients sometimes try to stretch it beyond its labeled schedule. We've written about why splitting pens to save money usually backfires. There are cheaper routes that don't involve guessing at your dose.
Insurance: why your plan may cover one and not the other
Ozempic usually sits on formulary for type 2 diabetes. Wegovy often doesn't get covered for weight loss alone — many commercial plans exclude anti-obesity medication outright, and Medicare Part D coverage for weight loss remains limited.
Which creates the central frustration in the Ozempic vs Wegovy decision: the drug you need may be the one your plan won't pay for, and the drug your plan pays for may not be legal for your prescriber to write for your indication.
Three things worth checking before you give up on coverage:
- Whether your plan covers Wegovy under its cardiovascular risk-reduction or MASH indications rather than weight loss
- Whether a prior authorization documenting BMI plus a weight-related condition changes the answer
- Whether your cash price is lower than your coinsurance — on a high-deductible plan it very often is
Can you switch from Ozempic to Wegovy?
Not as a straight substitution. They're different products with different labels, so a switch means a new prescription.
If you've been taking Ozempic off-label for weight loss, moving to Wegovy is often the cleaner path — same drug, label that matches the reason you're taking it, access to the higher maintenance dose. If you're taking Ozempic for type 2 diabetes, Wegovy isn't approved for that, so a switch would mean giving up the indication your treatment is built around.
Dose carries over sensibly. Someone stable on 1 mg Ozempic typically doesn't restart Wegovy at 0.25 mg. That's a prescriber call, not a DIY one.
Savings tips for either drug
- Compare all three cash routes before you fill. Novo's direct self-pay price, a cash-pay network like CanAmerica Plus, and your insurance copay can each come out ahead depending on dose and plan.
- Check the pill price at your dose. The gap between $149 and $499 a month is the difference between staying on treatment and stopping.
- Ask about the lowest effective dose. If you're doing well at 1 mg, there's no clinical prize for climbing to 2 mg — and on Ozempic that step costs an extra $150 a month.
- Confirm the pharmacy is licensed and verified before buying anything semaglutide online. The shortage years left behind a lot of gray-market sellers.
- Skip compounded semaglutide. With the shortage resolved, large-scale compounding is no longer permitted, and potency in unregulated products is a real gamble.
The bottom line
Wegovy and Ozempic are the same medicine aimed at different problems. For weight management, Wegovy's higher ceiling dose means meaningfully more weight loss, and at cash-pay prices it usually costs less per milligram than Ozempic does. For type 2 diabetes, Ozempic is the approved option and prices identically at common doses.
Price both at your actual dose and format before you commit — you can check current cash pricing for Ozempic and Wegovy on CanAmerica Plus, then bring the numbers to the appointment where the prescription gets decided.
Frequently asked questions
Which is cheaper, Ozempic or Wegovy?
At the same starting doses they're priced the same on self-pay, around $349 a month for the injection and $149 for the pill. At maintenance, Wegovy is usually cheaper per milligram of semaglutide, and Ozempic's 2 mg dose is the most expensive injection option of the two at roughly $499 a month.
Can I take Ozempic for weight loss instead of Wegovy?
Prescribers do write Ozempic off-label for weight loss, but it caps at 2 mg weekly, so the weight-loss ceiling is lower than Wegovy's. Off-label use also tends to complicate coverage. It's a legitimate conversation to have with your doctor, not something to arrange around them.
Is there a generic version of either one?
No. Semaglutide is still under patent protection in the US, and no generic Ozempic or Wegovy is commercially available. Our Ozempic generic update covers where the patents stand and what's realistic on timing.
How do Ozempic and Wegovy compare to Zepbound and Mounjaro?
Zepbound and Mounjaro contain tirzepatide, which targets two hormone receptors rather than one and has produced larger average weight loss in head-to-head data. The same label split applies: Zepbound for weight, Mounjaro for diabetes. See our Zepbound vs Wegovy comparison for the cost side.
What about Rybelsus — isn't that semaglutide too?
It is. Rybelsus was the original oral semaglutide for type 2 diabetes, dosed up to 14 mg daily. The newer Ozempic and Wegovy tablets go higher, which is why the weight-management pill route runs through them instead.
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment. Pricing information is current as of the publication date but may change. Verify pricing directly before making purchasing decisions.